Atossa Genetics (ATOS) Announces CAR-T Program in Breast Cancer – Zacks Small Cap Research (press release)
|
Atossa Genetics (ATOS) Announces CAR–T Program in Breast Cancer
Zacks Small Cap Research (press release) On October 2, Atossa Genetics (NASDAQ:ATOS) announced a new program using Chimeric Antigen Receptor Therapy (CAR-T). The company plans to use its proprietary intraductal microcatheter technology to deliver CAR–T cells into the ducts of the breast … |
